Immunotherapy for childhood eczema [ 2014 - 2018 ]

Research Grant

Researchers: Prof Barry Marshall (Principal investigator) ,  A/Pr Mohammed Benghezal ,  A/Pr Peter Richmond ,  Dr Alma Fulurija ,  Dr Debra Palmer
View all 8 related researchers

Brief description The aim of this proposal is to test the safety of a novel immunotherapy based on Helicobacter pylori platform technology to treat childhood allergies. Repeated oral administration of killed H. pylori mimics colonisation in the stomach and assists the development of a balanced immune system without the associated disease risk of live H. pylori. To achieve this goal Professor Barry Marshall has assembled a cross-disciplinary team of experts from Industry, Academia and Clinic.

Funding Amount $AUD 965,300.17

Funding Scheme Development Grants

Notes Development Grant